Sutro Biopharma (STRO) Stock Price, Quote, News & History | Benzinga

Sutro Biopharma Inc (STRO) Stock Price, Quote, News & History

STRONASDAQ

Trade with Public

Trade with Public

$21.04

-0.12-0.57%

At close: Aug 21, 5:00 PM EST

$21.04

N/A

After Hours: Aug 21, 4:00 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$21.39

Close

$21.04

Volume / Avg.

194.68K / 361.47K

Day Range

$20.84 - $21.86

52 Wk Range

7.15 - 43.85

Market Cap

$348.87M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

10.56%

Days to Cover

6.35

Recent Sutro Biopharma Inc News

Why is Sutro Biopharma Stock Falling On Wednesday?

Sutro Biopharma stock falls after its STRO-004 Phase 1 update, with DLTs reported at the highest dose and the next update planned for 2027.

Vandana Singh

Gold Gains 1%; Performance Food Group Shares Fall After Q4 Results

Dow Jones up 0.1%, NASDAQ up 0.47%, S&P 500 up 0.24%. Tech stocks up 1.1%, communication services down 1.3%. Performance Food Group shares down 6% after reporting earnings miss. AII up 17%, EROC up 20%, BOXL up 69%. NCMI down 31%, UAMY down 22%, STRO down 16%. Oil down 0.1%, gold up 1.1%. Eurozone mixed, Asian markets close mixed. CPI rises 3.4% year-over-year in July.

Avi Kapoor

XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures lower with Nasdaq down 200 points. XP Inc (XP) falls after reporting lower-than-expected earnings and naming new CFO. Other stocks also trading lower.

Avi Kapoor

Why Agilysys Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial results and issuing positive sales guidance. Other notable gainers and losers in pre-market trading include AMST, HAO, MTVA, ONCO, SDA, PIII, VRAX, PURR, BKKT, WOK, BTM, and UBXG.

Avi Kapoor

Gemini Space Posts Upbeat Q1 Results, Joins Figma, Sutro Biopharma And Other Big Stocks Moving Higher On Friday

Dow Jones falls 400 points, while Gemini Space Station Inc (NASDAQ: GEMI) sees 25.7% jump after strong financial results and $100M investment.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-145.17M

Investing Cash Flow (TTM)

32.79M

Financing Cash Flow (TTM)

102.70M

Free Cash Flow (TTM)

-145.62M

Capital Expenditure (TTM)

-446.00K

Net Change in Cash (TTM)

-9.69M

Analyst Trends and Forecast

3

Mar

2

Apr

4

May

1

Jun

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$195.30M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

5.41

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-82.05%

Earnings Yield % (FWD)

-44.92%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$6.23

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$54.34M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$21.39

Close

$21.04

Volume / Avg.

194.68K / 361.47K

Day Range

$20.84 - $21.86

52 Wk Range

7.15 - 43.85

Market Cap

$348.87M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

37

Short Interest

10.56%

Days to Cover

6.35

About

Sector

Health Care

Industry

Biotechnology

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein syn...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Sutro Biopharma (STRO) stock?

A

You can purchase shares of Sutro Biopharma (NASDAQ:STRO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sutro Biopharma (STRO) competitors?

A

Other companies in Sutro Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Sutro Biopharma (STRO) stock?

A

Sutro Biopharma has a consensus price target of $26.52.

Q

What is the current price for Sutro Biopharma (STRO)?

A

The stock price for Sutro Biopharma (NASDAQ: STRO) is $21.04 last updated August 21, 2026 at 4:00 PM EDT.

Q

Does Sutro Biopharma (STRO) pay a dividend?

A

There are no upcoming dividends for Sutro Biopharma.

Q

When is Sutro Biopharma (NASDAQ:STRO) reporting earnings?

A

Sutro Biopharma does not have any upcoming earnings scheduled.

Q

Is Sutro Biopharma (STRO) going to split?

A

There is no upcoming split for Sutro Biopharma.

Q

What sector and industry does Sutro Biopharma (STRO) operate in?

A

Sutro Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.